MedTech Sustainability by Design

Can one product be a drug and a medical device at the same time? Subhi Saadeh, founder of Let's Combinate and host of the Let's Combinate podcast, has spent his career at that line, from IV bags at Baxter to device quality on the mRNA flu vaccine at Pfizer. In this episode: - The three types of combination products: integral, co-packaged and cross-labeled - Why pharma and device teams us...

A special episode hosted by Swiss Medtech, with Barbara Mettler asking the questions. Prof. Dr. Martin Scheringer from ETH Zurich, toxicologist Arne Jaksch and Lucas Pianegonda work through what medtech companies should actually do about PFAS this year. In this episode: - Where PFAS sit beyond the product: process water, piping, cooling and cutting fluids, packaging, processing aids - Why your sup...

From September 2026, the EU stops accepting green claims that nobody has verified. Self-certified labels are banned. Fines run up to 4% of annual revenue. I talked to James Connelly, CEO of My Green Lab, the non-profit behind the ACT Ecolabel, the first third-party verified eco-label for laboratory products. Over 5,300 labs in 62 countries have engaged with My Green Lab certification, including 42...

European hospitals are already scoring sustainability in tenders. Joachim Almdal from Care Pathway Consulting explains why the device is only 10 to 15% of the emissions across a care pathway, and why that changes what you optimise and who you have to convince. In this episode: - What a care pathway is, and why looking at the device alone moves the problem around instead of solving it - Why Europea...

Why are most catheters still glued and heat-shrunk together by hand? Simone Maccagnan from Gimac International makes the case for microextrusion: single continuous parts, controlled molecular weight and crystallinity, and dynamic extrusion that changes stiffness along one tube. In this episode: - How microextrusion replaces multi-part catheter assemblies, and why that matters for validation, scrap...

What is the most sustainable catheter we could design from scratch today? Damian Carr, founder of Eyedea MedTech Education and author of the Catheter R&D Handbook, joins me for a full case study. We break down how catheters are built today, why the process is still manual and fluoropolymer-heavy, and what a modern reel-to-reel line would look like. We cover PFAS-free liners, UHMWPE, dynamic co...

Can bio-based plastic move past the nice story and scale in regulated MedTech? Tim Wagler is Commercial Director EMEA for Braskem's I'm green bio-based portfolio, polyethylene made from sugarcane instead of fossil feedstock. Braskem just launched an I'm green bio-based medical grade. In this episode: - What "physical content" bio-based means and how it differs from mass ba...

How does a company with 120,000 colleagues and 500,000 products put a number on its carbon footprint and actually act on it? Matthew Yamatin is Global Director Sustainability at Thermo Fisher Scientific. He built the corporate sustainability program from scratch after joining in 2022 and now runs it across eight business groups. In this episode: - The scalable method Thermo Fisher uses to calculat...

"Do not do ego-design." A professor told Bart Verleije that in school, and it shaped how he has built medical devices ever since. Bart is Commercial Director at Voxdale, a Belgian design and engineering firm, with more than 1,400 projects over 19 years. He explains how a napkin sketch becomes a certified, manufacturable device, and where most MedTech projects go wrong before they reach a...

Most sustainable plastics cost two to six times more than oil-based alternatives. That's why you don't see them everywhere. Alex Braun decided to fix that. Alex is the Chairman of Pillar Ltd, an Israeli industrial R&D company with 26 years of experience building materials for the world's largest manufacturers. Out of that work came three startups: PlasticBack, which chemically r...

Over a billion autoinjectors are used every year. Almost all of them are single-use. Almost all of that plastic gets incinerated. John Palmer-Felgate spent 30 years designing medical devices. At some point, he decided to actually fix the problem. John is the Founder and CTO of Eco-Inject, a UK startup that has built a sustainable autoinjector from the ground up using 100% bio-based polymers, fewer...

A lot of MedTech companies treat CAPA as a compliance exercise. They open a record, close a record, and survive the audit. Georg Digel has spent his career watching what happens when that's the only goal… and it's not pretty. Georg is the Founder and Owner of Elevate CAPA. He has spent years helping MedTech companies build CAPA systems that actually work: ones that identify real problems...

This episode is brought to you by Vanguard, a company specializing in remanufacturing single-use medical devices to as-good-as-new condition. A device labeled "single-use" gets thrown away after one patient. That makes sense for a syringe. It makes a lot less sense for a cardiac catheter that costs thousands of euros. Ulrike Marczak is the CEO of Vanguard, a company that has been remanuf...

Bastien Manuel recognized that sustainability was inevitable for most medical plastic manufacturers. At elmplastic,  he proactively established his business with that future in mind. He's Commercial Director at elm-plastic GmbH, a Germany-based, family-owned converter of plastic and manufacturer of pharmaceutical plastic devices. In 2025, they launched what they believe is the only commercial...

This episode is brought to you by Synera Advisory. Most MedTech founders treat FDA clearance like it's the finish line. Jordan Morrison has an entire bookshelf of cleared devices that can't sell to prove it isn't. She's Founding Partner at Synera Advisory, a physician-backed advisory group supporting founders from concept through commercialization. In this episode, she explains...

This episode is brought to you by FKuR Kunststoff GmbH, a leading producer and distributor of bio-based and compostable plastics. "Recycling is just an extension of linearity." Patrick Zimmermann posts the same sentence on LinkedIn, and it always gets a reaction:  He's the Managing Director at FKuR Kunststoff GmbH, a company that's been working with bio-based and compostable pl...

If you want to make your medical devices more sustainable, let's talk—: https://calendly.com/lucas-pianegonda-gradical/discovery-call-gradical Most MedTech founders build the wrong device because they skip the steps that actually matter before the engineering starts. Lisa Voronkova is CEO of OVA Solutions, an R&D shop that has developed over 200 medical devices from scratch, and author of...

If you want to make your medical devices more sustainable, let's talk: https://calendly.com/lucas-pianegonda-gradical/discovery-call-gradical What if you could cut the time it takes to develop a medical device in half? In this episode, I sit down with Prof. Dr. Christian Johner, founder of the Johner Institute and one of Europe's most recognized experts in medical device, regulatory affa...

If you're a MedTech company struggling to make your devices more sustainable, let’s talk—BOOK A CALL HERE: https://calendly.com/lucas-pianegonda-gradical/discovery-call-gradical What if the plastic in your current medical device ends up restricted before your product reaches the end of life? Julian Lotz, CEO and Co-Founder of BIOVOX, joins the podcast to talk about where material compliance i...

This episode is sponsored by Sterilis Solutions: https://sterilissolutions.com "How much is medical waste actually costing us?" is one of the questions hospitals are finally asking out loud. The problem is, most facilities don't realize they're dealing with a 10-20% annual cost increase—plus safety risks and sustainability pressure that isn't going away. In this episode, I...

"Is this material going to be biocompatible?" is one of the most commonly asked questions in medical device development. The problem is, there's no such thing as a biocompatible material. In this episode, I speak with Marina Daineko, Biocompatibility Consultant at Intrinsic Medical Group, about how biological risk assessment actually works, what mistakes companies make early in deve...

Chemical recycling is often presented as a silver bullet. But is it actually viable for medical-grade plastics? In this episode, I speak with Reinier Grimbergen , CTO of Blue Circle Olefins, about what chemical recycling really is, how it differs from mechanical recycling, and where it actually makes sense for MedTech. This conversation is technical, practical, and grounded in industrial reality....

Why does it take so long to bring a medical device to market? And what can we actually do about it? Spencer Jones is a serial entrepreneur and the founder of XO MedTech and MedTech Vendors. In this episode, he breaks down the real problems slowing innovation in medical technology and shares practical solutions that work. This isn't about motivation. It's about the structural issues that...

If you are building or scaling a medical device, sterilization problems will catch up with you. Usually later in the process than you want. In this episode, I speak with Manuel Grandy, Consultant and Managing Partner at SteriComp GmbH , about what sterilization actually means in practice and why so many teams underestimate it until regulators start asking uncomfortable questions. We talk about ETO...

Many companies say sustainability matters, but only a few treat it as part of their strategy. One of them is Ambu , a global MedTech company and the market leader in single-use endoscopy. In this episode, Casper Venbjerg Hansen, Senior Director, Sustainability, Public Affairs, Risk and Compliance at Ambu A/S , explains how sustainability guides their decisions and why Ambu committed to it early. C...